Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.3250
-0.0650 (-2.72%)
NASDAQ· Last Trade: Sep 15th, 11:29 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors